[EN] 2-CYANO-3-CYCLOPROPYL-3-HYDROXY-N-ARYL-THIOACRYLAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE 2-CYANO-3-CYCLOPROPYL-3-HYDROXY-N-ARYL-THIOACRYLAMIDE
申请人:ALGIAX PHARMACEUTICALS GMBH
公开号:WO2015140081A1
公开(公告)日:2015-09-24
A compound of the formula (I) or a tautomeric isoform thereof wherein R1 is selected from the group consisting of halogen, nitro, lower alkyl sulfonyl, cyano, trifluromethyl lower alkyl, lower alkoxy, lower alkoxycarbonyl, carboxy, lower alkyl aminosulfonyl, perfluoro lower alkyl, lower alkylthio, hydroxy lower alkyl, alkoxy lower alkyl, lower alkylthio lower alkyl, lower alkylsulfinyl lower alkyl, lower alkylsulfonyl lower alkyl, lower alkylsulfinyl, lower alkanoyl, aroyl, aryl, aryloxy and R2 is selected from the group consisting of hydrogen, alkyl, alkoxy, alkylthio, and alkylcarbonyl, and their non-toxic, pharmaceutically acceptable base addition salts or pro-drugs thereof. The compounds of the invention are useful in the treatment of nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex.
该化合物的结构式(I)或其互变异构体,其中R1被选自卤素、硝基、较低烷基磺酰基、氰基、三氟甲基较低烷基、较低烷氧基、较低烷氧羰基、羧基、较低烷基氨基磺酰基、全氟较低烷基、较低烷基硫基、羟基较低烷基、烷氧基较低烷基、较低烷硫基较低烷基、较低烷基亚砜基较低烷基、较低烷基砜基较低烷基、较低烷基亚砜基、较低烷酰基、芳酰基、芳基、芳氧基以及R2被选自氢、烷基、烷氧基、烷硫基和烷羰基的群组,以及它们的非毒性、药学上可接受的碱加盐或前药。该发明的化合物在治疗对GABAA受体复合物调节敏感的神经系统疾病和障碍方面具有用处。